Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 81 | Hukyndra | Authorised | adalimumab | Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid;Colitis, Ulcerative;Crohn Disease;Hidradenitis Suppurativa;Psoriasis;Spondylitis, Ankylosing;Uveitis | Stada Arzneimittel AG | 14-09-2021 |
| 82 | Abevmy | Authorised | bevacizumab | Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | Biosimilar Collaborations Ireland Limited | 24-02-2021 |
| 83 | Vegzelma | Authorised | bevacizumab | Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | Celltrion Healthcare Hungary Kft. | 20-06-2022 |
| 84 | Oyavas | Authorised | bevacizumab | Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADA Arzneimittel AG | 15-04-2021 |
| 85 | Aybintio | Authorised | bevacizumab | Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | Samsung Bioepis NL B.V. | 02-09-2020 |
| 86 | Herzuma | Authorised | trastuzumab | Stomach Neoplasms;Breast Neoplasms | Celltrion Healthcare Hungary Kft. | 23-08-2018 |
| 87 | Mvasi | Authorised | bevacizumab | Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | Amgen Technology (Ireland) UC | 12-02-2018 |
| 88 | Avtozma | Authorised | tocilizumab | Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | Celltrion Healthcare Hungary Kft. | 13-12-2024 |
| 89 | Ontruzant | Authorised | trastuzumab | Stomach Neoplasms;Breast Neoplasms | Samsung Bioepis NL B.V. | 13-08-2018 |
| 90 | Abasaglar (previously Abasria) | Authorised | insulin glargine | Diabetes Mellitus | Eli Lilly Nederland B.V. | 27-02-2018 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.